BriaCell Therapeutics Corp. (BCTX) stock
BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
$3.51−0.08 (-2.23%)
Close on Nov 12, 2026Market cap $30.65MP/E –Yield –
BriaCell Therapeutics cash
Cash and short-term investments held at the end of each period.
BriaCell Therapeutics's cash was $20.54M at Jul 31, 2026. For fiscal 2026 it was $20.54M, up 15.0% from the year before. The highest annual figure on record is $57.27M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jul 31, 2026 | $20.54M | +15.0% |
| FY2025 | Jul 31, 2025 | $17.87M | +1972.4% |
| FY2024 | Jul 31, 2024 | $862.09K | -95.9% |
| FY2023 | Jul 31, 2023 | $21.25M | -48.2% |
| FY2022 | Jul 31, 2022 | $41.04M | -28.3% |
| FY2021 | Jul 31, 2021 | $57.27M | +269412.4% |
| FY2020 | Jul 31, 2020 | $21.25K | -97.2% |
| FY2019 | Aug 1, 2019 | $763.90K | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jul 31, 2026 | $20.54M | +15.0% |
| Q3 FY2026CQ1 2026 | Apr 30, 2026 | $22.80M | +83.0% |
| Q2 FY2026CQ4 2025 | Jan 31, 2026 | $29.90M | +496.4% |
| Q1 FY2026CQ3 2025 | Oct 31, 2025 | $10.18M | +75.7% |
| Q4 FY2025CQ2 2025 | Jul 31, 2025 | $17.87M | +1972.4% |
| Q3 FY2025CQ1 2025 | Apr 30, 2025 | $12.46M | +1231.7% |
| Q2 FY2025CQ4 2024 | Jan 31, 2025 | $5.01M | -19.7% |
| Q1 FY2025CQ3 2024 | Oct 31, 2024 | $5.79M | -57.6% |
| Q4 FY2024CQ2 2024 | Jul 31, 2024 | $862.09K | -95.9% |
| Q3 FY2024CQ1 2024 | Apr 30, 2024 | $935.69K | -96.7% |
| Q2 FY2024CQ4 2023 | Jan 31, 2024 | $6.24M | -81.4% |
| Q1 FY2024CQ3 2023 | Oct 31, 2023 | $13.65M | -63.6% |
| Q4 FY2023CQ2 2023 | Jul 31, 2023 | $21.25M | -48.2% |
| Q3 FY2023CQ1 2023 | Apr 30, 2023 | $28.17M | -36.7% |
| Q2 FY2023CQ4 2022 | Jan 31, 2023 | $33.50M | -30.2% |
| Q1 FY2023CQ3 2022 | Oct 31, 2022 | $37.45M | -34.6% |
| Q4 FY2022CQ2 2022 | Jul 31, 2022 | $41.04M | +104.6% |
| Q3 FY2022CQ1 2022 | Apr 30, 2022 | $44.53M | +747878.6% |
| Q2 FY2022CQ4 2021 | Jan 31, 2022 | $47.98M | +225706.8% |
| Q4 FY2021CQ2 2021 | Jul 31, 2021 | $57.27M | +7396.9% |
| Q3 FY2021CQ1 2021 | Apr 30, 2021 | $20.06M | – |
| Q2 FY2021CQ4 2020 | Jan 31, 2021 | $5.95K | – |
| Q4 FY2020CQ2 2020 | Jul 31, 2020 | $21.25K | – |
| Q4 FY2019CQ2 2019 | Aug 1, 2019 | $763.90K | – |
See a number that looks wrong?